| Veröffentlichte Version Download ( PDF | 575kB) | Lizenz: Creative Commons Namensnennung 4.0 International |
Continuous decline of hepatitis E virus seroprevalence in southern Germany despite increasing notifications, 2003–2015
Mahrt, Hannah, Schemmerer, Mathias
, Behrens, Gundula
, Leitzmann, Michael, Jilg, Wolfgang und Wenzel, Jürgen J.
(2018)
Continuous decline of hepatitis E virus seroprevalence in southern Germany despite increasing notifications, 2003–2015.
Emerging Microbes & Infections 7, S. 133.
Veröffentlichungsdatum dieses Volltextes: 07 Aug 2018 05:38
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.37556
Zusammenfassung
Hepatitis E virus (HEV) is viewed as an emerging pathogen. Many European countries, including Germany, have observed a steep increase of notified autochthonous hepatitis E cases in recent years. Our study investigated time trends in HEV seroprevalence in southern Germany between 2003 and 2015. A total of 3000 study sera were evenly distributed over sampling years 2003, 2006, 2009, 2012, and 2015, ...
Hepatitis E virus (HEV) is viewed as an emerging pathogen. Many European countries, including Germany, have observed a steep increase of notified autochthonous hepatitis E cases in recent years. Our study investigated time trends in HEV seroprevalence in southern Germany between 2003 and 2015. A total of 3000 study sera were evenly distributed over sampling years 2003, 2006, 2009, 2012, and 2015, two age groups (20-29 and 30-39 years) and genders and were tested for anti-HEV IgG. Positive samples were quantified. The seroprevalence declined from 32.8% in 2003 over 22.5% in 2006 (p < 0.001) and 22.3% in 2009 to 17.7% and 17.8% in 2012 and 2015. A higher prevalence was found for males (p = 0.018) and the older age group (p < 0.001). Anti-HEV IgG concentrations ranged from 0.22 to 1783.19 WU mL(-1). A higher median concentration (2.41 vs. 1.89 WU mL(-1), p < 0.001) was found in the younger age group. The anti-HEV IgG seroprevalence decreased since 2003 and remains constant at similar to 18% since 2012. A rather low anti-HEV prevalence in young adults is indicative of a susceptible population and denotes a higher risk of HEV infections in this age group in the future. Therefore, reduction of HEV infection sources, close monitoring, and vigilance for proper control measures are warranted.
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||||
| Titel eines Journals oder einer Zeitschrift | Emerging Microbes & Infections | ||||||
| Verlag: | Nature | ||||||
|---|---|---|---|---|---|---|---|
| Ort der Veröffentlichung: | LONDON | ||||||
| Band: | 7 | ||||||
| Seitenbereich: | S. 133 | ||||||
| Datum | 25 Juli 2018 | ||||||
| Institutionen | Medizin > Lehrstuhl für Medizinische Mikrobiologie und Hygiene Medizin > Institut für Epidemiologie und Präventivmedizin | ||||||
| Identifikationsnummer |
| ||||||
| Stichwörter / Keywords | SOUTHEASTERN GERMANY; ANTIBODY PREVALENCE; HEV; INFECTION; TRANSMISSION; PERFORMANCE; HUMANS; EUROPE; IGM; | ||||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||||
| Status | Veröffentlicht | ||||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||||
| An der Universität Regensburg entstanden | Ja | ||||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-375563 | ||||||
| Dokumenten-ID | 37556 |
Downloadstatistik
Downloadstatistik